Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica

Antimicrobial Agents and Chemotherapy
Deborah J EavesL J Piddock

Abstract

Salmonella enterica isolates (n = 182) were examined for mutations in the quinolone resistance-determining region of gyrA, gyrB, parC, and parE. The frequency, location, and type of GyrA substitution varied with the serovar. Mutations were found in parC that encoded Thr57-Ser, Thr66-Ile, and Ser80-Arg substitutions. Mutations in the gyrB quinolone resistance-determining region were located at codon Tyr420-Cys or Arg437-Leu. Novel mutations were also found in parE encoding Glu453-Gly, His461-Tyr, Ala498-Thr, Val512-Gly, and Ser518-Cys. Although it is counterintuitive, isolates with a mutation in both gyrA and parC were more susceptible to ciprofloxacin than were isolates with a mutation in gyrA alone.

References

Oct 1, 1987·Epidemiology and Infection·L R WardB Rowe
Jun 1, 1980·Journal of Clinical Pathology·C R Shipp, B Rowe
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·J BjörkmanD I Andersson
Jun 23, 2001·The Journal of Antimicrobial Chemotherapy·J M Andrews
May 15, 2002·FEMS Microbiology Reviews·Laura J V Piddock
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Frank Møller AarestrupE John Threlfall
Apr 23, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Heike Hansen, Peter Heisig
May 23, 2003·Antimicrobial Agents and Chemotherapy·Beatriz GuerraReiner Helmuth
Jul 3, 2003·The Journal of Antimicrobial Chemotherapy·Gunnar KahlmeterAlkiviadis Vatopoulos
Oct 25, 2003·Antimicrobial Agents and Chemotherapy·J M LingA F Cheng

❮ Previous
Next ❯

Citations

Jul 1, 2009·Epidemiology and Infection·A M SmithUNKNOWN Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA)
Nov 6, 2010·Epidemiology and Infection·Jan Walther-Rasmussen, Niels Høiby
Jun 29, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kathryn GayDavid C Hooper
Aug 13, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Haeng Soon JeongJeong Nyeo Lee
Nov 13, 2008·The Journal of Antimicrobial Chemotherapy·Aurora García-FernándezAlessandra Carattoli
Jul 15, 2009·Antimicrobial Agents and Chemotherapy·Marianne GunellLaura J V Piddock
Jun 17, 2009·Antimicrobial Agents and Chemotherapy·Anna Maria DionisiLaura Villa
Apr 28, 2010·Antimicrobial Agents and Chemotherapy·Il Kwon BaeGun-Jo Woo
Jan 24, 2008·Antimicrobial Agents and Chemotherapy·John A CrumpUNKNOWN Emerging Infections Program FoodNet and NARMS Working Groups
May 27, 2005·Antimicrobial Agents and Chemotherapy·Hidemasa IzumiyaHaruo Watanabe
Feb 17, 2009·Applied and Environmental Microbiology·Francisco J RoigC Amaro
Oct 31, 2008·Journal of Clinical Microbiology·Tzonyo DimitrovM John Albert
Mar 7, 2006·Journal of Clinical Microbiology·François-Xavier WeillPatrick A D Grimont
Mar 1, 2011·BMC Microbiology·Sreela S NamboodiriIruka N Okeke
Jun 8, 2012·The Journal of Veterinary Medical Science·Truong Ha ThaiRyoji Yamaguchi
Jan 14, 2004·Emerging Infectious Diseases·Teresa BastidaCarles Alonso-Tarrés
May 18, 2006·Emerging Infectious Diseases·Satheesh NairNarasimha Harish
Jan 26, 2008·Emerging Infectious Diseases·Jean M WhichardTimothy J Barrett
Oct 12, 2010·Journal of Global Infectious Diseases·Malini Rajinder Capoor, Deepthi Nair
Apr 8, 2014·The Journal of Antimicrobial Chemotherapy·Anna FàbregaJordi Vila
Jun 10, 2015·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Cheng-Yen KaoJiunn-Jong Wu
Mar 15, 2011·Diagnostic Microbiology and Infectious Disease·Patrícia AntunesLuísa Peixe
Dec 20, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Kwai Lin ThongCindy Shuan Ju Teh
Oct 9, 2015·The Journal of Antimicrobial Chemotherapy·Clara Ballesté-DelpierreJordi Vila

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.